|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03689 KANGHUA HEALTH
Nominal 
1.950 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,055,670 | 0.676% | 2,041,858 | 1,845,633 | 1,953,944 | 1,745,023 |
| Cost of Sales | (1,733,797) | 3.357% | (1,677,488) | (1,584,283) | (1,601,196) | (1,481,868) |
| Gross Profit | 321,873 | -11.663% | 364,370 | 261,350 | 352,748 | 263,155 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,277) | 54.516% | (2,768) | (4,210) | (18,443) | (75,553) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 63,055 | -58.903% | 153,429 | 69,309 | 129,209 | (26,089) | |
| Taxation | (52,582) | -15.742% | (62,406) | (43,025) | (62,284) | (23,967) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,864 | -83.808% | 30,039 | 33,413 | 27,382 | 24,684 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 15,337 | -87.331% | 121,062 | 59,697 | 94,307 | (25,372) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 17,627 | 146.981% | 7,137 | 11,817 | 17,943 | 17,957 |
| Depreciation & Amortisation | 149,855 | 4.736% | 143,079 | 149,441 | 149,443 | 142,888 |
| Directors' Emoluments | 3,625 | 45.407% | 2,493 | 3,103 | 3,040 | 3,068 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 4.600 | -87.293% | 36.200 | 17.900 | 28.200 | -7.600 |
| DPS (cts) | 15.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 326.087% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.611 | 0.662 | 0.997 | 0.823 |
| NBV per share ($) | 5.758 | -- | 4.259 | 4.483 | 4.267 | 3.985 |
| Remarks: | Real time quote last updated: 16/04/2025 17:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 15,337 |
| %Change | -87.331% |
| EPS / (LPS) | RMB 0.046 |
| NBV Per Share (¥) | RMB 5.758 |